Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Ryman Healthcare Ltd (RH7.BE)

1.2140
-0.0220
(-1.78%)
As of 12:45:01 PM GMT+2. Market Open.
Loading Chart for RH7.BE
  • Previous Close 1.2360
  • Open 1.2140
  • Bid 1.0440 x --
  • Ask 1.4010 x --
  • Day's Range 1.2130 - 1.2140
  • 52 Week Range 1.2130 - 2.8100
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: RH7.BE

View More

Performance Overview: RH7.BE

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .

YTD Return

RH7.BE
52.39%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
8.34%

1-Year Return

RH7.BE
49.63%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
0.60%

3-Year Return

RH7.BE
76.79%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
0.92%

5-Year Return

RH7.BE
80.76%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
15.34%

Compare To: RH7.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RH7.BE

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    1.24B

  • Enterprise Value

    2.60B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.55

  • Price/Book (mrq)

    0.56

  • Enterprise Value/Revenue

    7.31

  • Enterprise Value/EBITDA

    435.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RH7.BE

View More

Company Insights: RH7.BE

Research Reports: RH7.BE

View More